This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Teva-Fluvastatin (2015-10-16)

Starting date:
October 16, 2015
Posting date:
October 26, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-55552

Affected Products

Teva-Fluvastatin

Reason

Potential labelling error, where a bottle of Teva-Venlafaxine XR 150 mg capsules is labelled with an upper peel off label of Teva-Fluvastatin Sodium 40 mg.

Affected products

Teva-Fluvastatin

DIN, NPN, DIN-HIM
DIN 02299232
Dosage form

Capsule

Strength

Fluvastatin 40 mg

Lot or serial number

W07681

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Date modified: